Eugenio Rivera, DPM
Foot & Ankle Surgery · Bellaire, TXNPI 1912029364
Payments from drug & device makers
Across 94 payments — averaging $77.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Paragon 28, Inc.$1K
- Arthrosurface Incorporated$1K
- Amgen$235
- Stryker$187
- Linvatec Corporation$165
- plus $895 from 13 others
What the payments were for
- Travel & lodging$4,45461%
- Food & beverage$2,79539%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 26 | $3,204 |
| Paragon 28, Inc. | 3 | $1,497 |
| Arthrosurface Incorporated | 7 | $1,067 |
| Amgen | 17 | $235 |
| Stryker | 7 | $187 |
| Linvatec Corporation | 1 | $165 |
| Abbott | 2 | $140 |
| Boehringer Ingelheim | 6 | $124 |
| Paratek Pharmaceuticals, Inc. | 6 | $119 |
| AbbVie | 1 | $106 |
| Medtronic | 1 | $96 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $82 |
| Smith+Nephew | 5 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $53 |
| Zimmer Biomet | 1 | $42 |
| Zyla Life Sciences, Inc. | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $13 |
| Kerecis Limited | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,607
- Product Portfolio$1,497
- LAPIPLASTY SYSTEM 1$869
- HemiCAP MTP Resurfacing$848
- NeoSpan$165
- BioBrace 23mm$165
- TMC NANOPLASTY SYSTEM$118
- DALVANCE$106
How this compares
$7,250 in reported general payments places this provider in the 65th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 98 | $1,632 |
| Terbinafine Hcl | 56 | $1,491 |
| Clotrimazole | 39 | $1,439 |
| Mupirocin | 153 | $1,307 |
| Cefadroxil | 128 | $1,189 |
| Diclofenac Sodium | 52 | $875 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $670 |
| Clobetasol Propionate | 18 | $648 |
| Gabapentin | 63 | $528 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 57 | $488 |
| Methylprednisolone | 56 | $478 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $391 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $273 |
| Colchicine | 13 | $229 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $178 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bellaire
- Michael GreaserBellaire$88K
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.